Nitrous oxide (N2O) is a potent greenhouse gas that both traps heat and destroys ozone, reducing Earth's protection from ...
They're exploring its use for groundbreaking treatments for cancer and autoimmune disease, as well as for gene-editing ...
Beam Therapeutics Inc. trades at a relatively cheap valuation based on its multiples and potential in SCD. Learn more about ...
Q3 2025 Earnings Call Transcript October 29, 2025 BridgeBio Pharma, Inc. misses on earnings expectations. Reported EPS is $-0 ...
Beijing Tsingke Biotech Co., Ltd., a pioneer in molecular manufacturing, showcased its next-generation integrated platforms at the 2025 Festival of Biologics in Basel. Over 2,000 biotech experts from ...
Net Loss -- Net loss was $13.6 million for the third quarter of 2025, compared to $16.4 million in Q3 2024. Ending Cash, Cash ...
Manhattan Associates, Inc. ( NASDAQ: MANH) Q3 2025 Earnings Call October 21, 2025 4:30 PM EDT ...
Hosted on MSN
Scientists fix genetic defect in mice tied to brain disorders that include autism and epilepsy
In an exciting scientific first, researchers at the Allen Institute successfully designed a new gene therapy that reversed symptoms related to SYNGAP1-related disorders (SRD) in mice. These are a ...
The global cancer-therapy landscape is undergoing a rapid evolution toward precision drug-delivery systems designed to boost efficacy, limit toxicity and elevate patient outcomes. Conventional oral ...
The Inflammatory Diseases Market, valued at USD 22.5 billion in 2025, is projected to reach USD 34.9 billion by 2035, ...
The anti-inflammatory biologics segment is anticipated to hold 41.5% of the market revenue in 2025, emerging as the dominant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback